Reviva Pharmaceuticals Holdings, Inc. Deferred Tax Assets, Tax Credit Carryforwards
Reviva Pharmaceuticals Holdings, Inc. (RVPH) had Deferred Tax Assets, Tax Credit Carryforwards of $231.43 thousand as of 2023-12-31, per its 10-K filed 2024-04-15.
Discontinued › Notes
us-gaap:DeferredTaxAssetsTaxCreditCarryforwards · last filed 2024-04-15
- 2023-12-31: Deferred Tax Assets, Tax Credit Carryforwards $231.43K.
- 2022-12-31: Deferred Tax Assets, Tax Credit Carryforwards $117.91K.
- 2021-12-31: Deferred Tax Assets, Tax Credit Carryforwards $81.91K.
- 2020-12-31: Deferred Tax Assets, Tax Credit Carryforwards $10.90K.
| Period end | Deferred Tax Assets, Tax Credit Carryforwards |
|---|---|
| 2023-12-31 | $231.43K 10-K · filed 2024-04-15 |
| 2022-12-31 | $117.91K 10-K · filed 2024-04-15 |
| 2021-12-31 | $81.91K 10-K · filed 2023-03-30 |
| 2020-12-31 | $10.90K 10-K · filed 2022-03-15 |
| 2019-12-31 | $14.40K 10-K/A · filed 2021-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |